TrumpRx to add over 600 generics
The TrumpRx scheme is set to increase its available drugs by nearly 7 times.
This expansion will include more than 600 generics.
The move aims to make healthcare more affordable for many people.
Callodine has exited its AQN stake, valued at $37M, citing slow growth and capped returns, while AQN yields 4.56% but lags the S&P 500.